Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways
Abstract Advances in cancer genomics have significantly expanded our understanding of cancer biology. However, the high cost of drug development limits our ability to translate this knowledge into precise treatments. Approved non-oncology drugs, comprising a large repository of chemical entities, of...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-025-00813-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|